Ownership history in XTX Topco Ltd · 10 quarters on record
This page tracks every 13F SEC filing in which XTX Topco Ltd reported a position in VANDA PHARMACEUTICALS INC (VNDA). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | REDUCED | 30,121 | -1,403 | -4.5% | 0.01% | $150K | $4.99 |
| 2025 Q2 | REDUCED | 31,524 | -37,805 | -54.5% | 0.01% | $149K | $4.72 |
| 2025 Q1 | ADDED | 69,329 | +54,833 | +378.3% | 0.02% | $318K | $4.59 |
| 2024 Q4 | ADDED | 14,496 | +1,218 | +9.2% | 0.01% | $69K | $4.79 |
| 2024 Q2 | REDUCED | 13,278 | -23,646 | -64.0% | 0.01% | $75K | $5.65 |
| 2023 Q4 | REDUCED | 36,924 | -25,590 | -40.9% | 0.03% | $156K | $4.22 |
| 2023 Q3 | ADDED | 62,514 | +37,109 | +146.1% | 0.05% | $270K | $4.32 |
| 2023 Q2 | REDUCED | 25,405 | -573 | -2.2% | 0.03% | $167K | $6.59 |
| 2023 Q1 | REDUCED | 25,978 | -20,724 | -44.4% | 0.04% | $176K | $6.79 |
| 2022 Q4 | INITIATED | 46,702 | — | — | 0.07% | $345K | — |
As of 2025 Q4 — sorted by position size